EIR Ventures

Type

Venture Capital

Status

Active

Location

Stockholm, Sweden

Total investments

11

Average round size

40M

Portfolio companies

10

Lead investments

3

Follow on index

0.09

Exits

1

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsLife SciencePharmaceuticalTherapeuticsBiopharmaBiometricsCollaborative ConsumptionClinical Trials

Investor highlights

Industry focus
Biotech/Life SciencesHealthcare
Stage focus
Seed
Geo focus
DenmarkFinlandIcelandNorwaySweden

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 122000000
Fund raised date
2021-12-09

Analytics

Total investments
11
Lead investments
3
Exits
1
Follow on index
0.09
Investments by industry
  • Biotechnology (9)
  • Health Care (5)
  • Pharmaceutical (3)
  • Therapeutics (2)
  • Biotechnology (2)
  • Show 10 more
Investments by region
  • Denmark (6)
  • United States (1)
  • Sweden (3)
  • Netherlands (1)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Moleculent 11 Jun 2024 Early Stage Venture 26M Stockholms Lan, Solna, Sweden

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.